73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study in mice examines impact of reused cooking oil on breast cancer progression

Study in mice examines impact of reused cooking oil on breast cancer progression

by Sharita Forrest ,University of Illinois at Urbana-ChampaignThe compounds in frying oils that are repeatedly reheated to high temperatures may trigger cell proliferation and metastases i

Study in mice examines impact of reused cooking oil on breast cancer progression

by Sharita Forrest ,University of Illinois at Urbana-ChampaignThe compounds in frying oils that are repeatedly reheated to high temperatures may trigger cell proliferation and metastases i
Understanding breast cancer recurrence, metastatic spread

Understanding breast cancer recurrence, metastatic spread

byUniversity of CincinnatiCredit: Unsplash/CC0 Public DomainDespite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researc

Understanding breast cancer recurrence, metastatic spread

byUniversity of CincinnatiCredit: Unsplash/CC0 Public DomainDespite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researc
Study finds a possible explanation for why immunotherapy works well for some cancer patients, but not others

Study finds a possible explanation for why immunotherapy works well for some cancer patients, but not others

by Yale UniversityCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0686Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack muta

Study finds a possible explanation for why immunotherapy works well for some cancer patients, but not others

by Yale UniversityCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0686Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack muta
Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer

Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer

by NRG OncologyCredit: Unsplash/CC0 Public DomainResults from the phase 3 NRG Oncology RTOG 0815 clinical study comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term an

Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer

by NRG OncologyCredit: Unsplash/CC0 Public DomainResults from the phase 3 NRG Oncology RTOG 0815 clinical study comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term an
Researchers develop new open-source method to improve decoding of single-cell data

Researchers develop new open-source method to improve decoding of single-cell data

by Ian Demsky,Memorial Sloan Kettering Cancer CenterSpectra uses gene sets and cell types to guide gene program discovery from scRNA-seq data.a, As input, Spectra receives a gene expressio

Researchers develop new open-source method to improve decoding of single-cell data

by Ian Demsky,Memorial Sloan Kettering Cancer CenterSpectra uses gene sets and cell types to guide gene program discovery from scRNA-seq data.a, As input, Spectra receives a gene expressio
Lymphoma mutation yields super-competitive immune cells

Lymphoma mutation yields super-competitive immune cells

by Heather Lindsey,Cornell UniversitySupercompetition in germinal centers leads to aggressive B cell lymphomas. GC B cells vigorously compete against each other to receive limiting T cell help,

Lymphoma mutation yields super-competitive immune cells

by Heather Lindsey,Cornell UniversitySupercompetition in germinal centers leads to aggressive B cell lymphomas. GC B cells vigorously compete against each other to receive limiting T cell help,
Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030
Team reports on development of potential new generic treatment for multiple types of cancer

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic
Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi
Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG
Study finds less invasive, safer option for removing benign pancreatic tumors

Study finds less invasive, safer option for removing benign pancreatic tumors

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainInsulinomas are abnormal tumors, usually benign, that grow in the beta cells of the pancreas. Insulinomas make extra insuli

Study finds less invasive, safer option for removing benign pancreatic tumors

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainInsulinomas are abnormal tumors, usually benign, that grow in the beta cells of the pancreas. Insulinomas make extra insuli
Online tool helps ovarian cancer patients feel more in control of symptoms

Online tool helps ovarian cancer patients feel more in control of symptoms

by University of PittsburghCredit: Unsplash/CC0 Public DomainAn online symptom management tool that harnesses the problem-solving benefits of expressive writing could help women with ovarian canc

Online tool helps ovarian cancer patients feel more in control of symptoms

by University of PittsburghCredit: Unsplash/CC0 Public DomainAn online symptom management tool that harnesses the problem-solving benefits of expressive writing could help women with ovarian canc